298
We report the first case of fulminant adult respiratory distress syndrome (ARDS) associated with pegylated interferon alpha-2a (pegIFNalpha-2a) and ribavirin use for hepatitis C, complicated by subsequent and ultimately fatal sepsis and multiorgan failure.
 adult respiratory distress syndrome (ARDS): Effect; pegylated interferon alpha-2a (pegIFNalpha-2a) and ribavirin: Treatment; pegylated interferon alpha-2a: Treatment.Drug; ribavirin: Treatment.Drug; hepatitis C: Treatment.Disorder
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 adult respiratory distress syndrome (ARDS): Effect; pegylated interferon alpha-2a (pegIFNalpha-2a) and ribavirin: Treatment; pegylated interferon alpha-2a: Treatment.Drug; ribavirin: Treatment.Drug; hepatitis C: Treatment.Disorder